Skip to content
★ Sign in to follow
ML
Total declarations
17
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (8 ops.)
€2.8M

Latest filing published 05 Nov 2013 for Illumina, INC., €136k.

Insider track record

Disclosed buys
0
Disclosed sells
8
Signal history

No signal scores available.

Mark L. Lewis: trading record in brief

Mark L. Lewis is a declared insider of Illumina, Inc., with filings sourced from SEC (Form 4). The record holds 17 filings, for trades running from 19 November 2012 to 1 November 2013.

On the market, this insider has only sold: 8 sales, €2.8M in total. Besides market trades, the filings include 2 share grants and 7 option exercises. Since January 2013: no purchases and 5 sales on the market.

The record was last updated on 5 November 2013 with an option exercise (€136k) in Illumina, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Mark L. Lewis

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total
  • ◇
    Sr VP & General ManagerExecutivesIllumina, Inc.
    185,200 USD0SEC
    5,000 shares@ US$37.04Common StockSEC:0001110803-13-000367:0
  • ▼
    Sr VP & General ManagerExecutivesIllumina, Inc.
    395,724 USD0SEC
    4,200 shares@ US$94.22Common StockSEC:0001110803-13-000367:1
  • ▼
    Sr VP & General ManagerExecutivesIllumina, Inc.
    75,816 USD0SEC
    800 shares@ US$94.77Common StockSEC:0001110803-13-000367:2
  • ◇
    Sr VP & General ManagerExecutivesIllumina, Inc.
    185,200 USD0SEC
    5,000 shares@ US$37.04Common StockSEC:0001110803-13-000297:0
  • ▼
    Sr VP & General ManagerExecutivesIllumina, Inc.
    390,600 USD0SEC
    5,000 shares@ US$78.12Common StockSEC:0001110803-13-000297:1
  • ◇
    Sr VP & General ManagerExecutivesIllumina, Inc.
    370,400 USD0SEC
    10,000 shares@ US$37.04Common StockSEC:0001110803-13-000229:0
  • ▼
    Sr VP & General ManagerExecutivesIllumina, Inc.
    716,400 USD0SEC
    10,000 shares@ US$71.64Common StockSEC:0001110803-13-000229:1
  • ◇
    Sr VP & General ManagerExecutivesIllumina, Inc.
    64,110 USD0SEC
    3,000 shares@ US$21.37Common StockSEC:0001110803-13-000229:2
  • ▼
    Sr VP & General ManagerExecutivesIllumina, Inc.
    216,000 USD0SEC
    3,000 shares@ US$72.00Common StockSEC:0001110803-13-000229:3
  • ◆
    Sr VP & General ManagerExecutivesIllumina, Inc.
    0SEC
    2,667 shares0Common StockSEC:0001110803-13-000059:0
  • ◆
    Sr VP & General ManagerExecutivesIllumina, Inc.
    48,781 USD0SEC
    945 shares@ US$51.62Common StockSEC:0001110803-13-000042:0
  • ◇
    Sr VP & General ManagerExecutivesIllumina, Inc.
    907,480 USD0SEC
    24,500 shares@ US$37.04Common StockSEC:0001110803-12-000184:0
  • ▼
    Sr VP & General ManagerExecutivesIllumina, Inc.
    1M USD0SEC
    24,500 shares@ US$56.21Common StockSEC:0001110803-12-000184:1
  • ◇
    Sr VP & General ManagerExecutivesIllumina, Inc.
    106,850 USD0SEC
    5,000 shares@ US$21.37Common StockSEC:0001110803-12-000182:0
  • ▼
    Sr VP & General ManagerExecutivesIllumina, Inc.
    259,350 USD0SEC
    5,000 shares@ US$51.87Common StockSEC:0001110803-12-000182:1
  • ◇
    Sr VP & GM Molecular BiologyExecutivesIllumina, Inc.
    106,850 USD0SEC
    5,000 shares@ US$21.37Common StockSEC:0001110803-12-000166:0
  • ▼
    Sr VP & GM Molecular BiologyExecutivesIllumina, Inc.
    250,000 USD0SEC
    5,000 shares@ US$50.00Common StockSEC:0001110803-12-000166:1

17 of 17 declarations